Carfilzomib in multiple myeloma. 2012

Ravi Vij
Section of Stem Cell Transplant and Leukemia, Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D061988 Proteasome Inhibitors Compounds that inhibit the function or proteolytic action of the PROTEASOME. Proteasome Endopeptidase Complex Inhibitors,Proteasome Inhibitor,Inhibitor, Proteasome,Inhibitors, Proteasome

Related Publications

Ravi Vij
November 2014, Expert opinion on biological therapy,
Ravi Vij
April 2018, Australian prescriber,
Ravi Vij
February 2015, Bulletin du cancer,
Ravi Vij
May 2017, Prescrire international,
Ravi Vij
December 2012, The Medical letter on drugs and therapeutics,
Ravi Vij
September 2019, Blood research,
Ravi Vij
January 2019, Cancer management and research,
Ravi Vij
August 2013, The Journal of pharmacy and pharmacology,
Ravi Vij
January 2018, The Lancet. Oncology,
Ravi Vij
March 2013, Drugs of today (Barcelona, Spain : 1998),
Copied contents to your clipboard!